Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

NOS3 894G>T polymorphism is associated with progression of kidney disease and cardiovascular morbidity in type 2 diabetic patients: NOS3 as a modifier gene for diabetic nephropathy

K. Kuricová, V. Tanhäuserová, L. Pácal, V. Bartáková, L. Brožová, J. Jarkovský, K. Kaňková,

. 2013 ; 38 (1) : 92-98.

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT11405 MZ0 CEP Register

BACKGROUND/AIMS: We have previously associated SNP 894G>T in the NOS3 gene with diabetic nephropathy (DN) using multi-locus analysis. Variant 894G>T has been widely studied as a DN susceptibility factor with contradictory results. In the present study we genotyped 894G>T in the cohort of prospectively followed type 2 diabetics with the aim to investigate its possible role in the progression of DN and development of morbidity and mortality associated with diabetes. METHODS: 311 subjects with defined stage of DN were enrolled in the study and followed up for a median of 38 months. We considered three end-points: progression of DN, major cardiovascular event and all-cause mortality. RESULTS: Considering baseline GFR, age at enrolment and diabetes duration as confounders, Cox regression analysis identified 894GT genotype as a risk factor for DN progression (HR = 1.843 [95% CI 1.088 - 3.119], P = 0.023) and 894TT genotype as a risk factor for major cardiovascular event (HR = 2.515 [95% CI 1.060 - 5.965], P = 0.036). CONCLUSION: We ascertained the significant effect of the NOS3 894G>T variant on DN progression and occurrence of major cardiovascular event in T2DM subjects. Based on these results NOS3 can be considered a modifier gene for DN.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008222
003      
CZ-PrNML
005      
20190611095505.0
007      
ta
008      
150306s2013 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000355757 $2 doi
035    __
$a (PubMed)24603156
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Chalásová, Katarína $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. $7 mub2017949800
245    10
$a NOS3 894G>T polymorphism is associated with progression of kidney disease and cardiovascular morbidity in type 2 diabetic patients: NOS3 as a modifier gene for diabetic nephropathy / $c K. Kuricová, V. Tanhäuserová, L. Pácal, V. Bartáková, L. Brožová, J. Jarkovský, K. Kaňková,
520    9_
$a BACKGROUND/AIMS: We have previously associated SNP 894G>T in the NOS3 gene with diabetic nephropathy (DN) using multi-locus analysis. Variant 894G>T has been widely studied as a DN susceptibility factor with contradictory results. In the present study we genotyped 894G>T in the cohort of prospectively followed type 2 diabetics with the aim to investigate its possible role in the progression of DN and development of morbidity and mortality associated with diabetes. METHODS: 311 subjects with defined stage of DN were enrolled in the study and followed up for a median of 38 months. We considered three end-points: progression of DN, major cardiovascular event and all-cause mortality. RESULTS: Considering baseline GFR, age at enrolment and diabetes duration as confounders, Cox regression analysis identified 894GT genotype as a risk factor for DN progression (HR = 1.843 [95% CI 1.088 - 3.119], P = 0.023) and 894TT genotype as a risk factor for major cardiovascular event (HR = 2.515 [95% CI 1.060 - 5.965], P = 0.036). CONCLUSION: We ascertained the significant effect of the NOS3 894G>T variant on DN progression and occurrence of major cardiovascular event in T2DM subjects. Based on these results NOS3 can be considered a modifier gene for DN.
650    _2
$a senioři $7 D000368
650    _2
$a kohortové studie $7 D015331
650    _2
$a diabetes mellitus 2. typu $x enzymologie $x genetika $7 D003924
650    _2
$a diabetická kardiomyopatie $x enzymologie $x epidemiologie $x genetika $7 D058065
650    _2
$a diabetické nefropatie $x enzymologie $x epidemiologie $x genetika $7 D003928
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a hodnoty glomerulární filtrace $7 D005919
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a synthasa oxidu dusnatého, typ III $x genetika $7 D052250
650    _2
$a polymorfismus genetický $x genetika $7 D011110
650    _2
$a prospektivní studie $7 D011446
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Tanhäuserová, Veronika $7 _AN049374
700    1_
$a Pácal, Lukáš $7 xx0084072
700    1_
$a Bartáková, Vendula $7 xx0240193
700    1_
$a Brožová, Lucie $7 xx0213022
700    1_
$a Jarkovský, Jiří, $d 1976- $7 stk2008461294
700    1_
$a Kaňková, Kateřina, $d 1971- $7 mzk2003190820
773    0_
$w MED00003064 $t Kidney & blood pressure research $x 1423-0143 $g Roč. 38, č. 1 (2013), s. 92-98
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24603156 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20190611095649 $b ABA008
999    __
$a ok $b bmc $g 1065495 $s 891022
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 38 $c 1 $d 92-98 $i 1423-0143 $m Kidney & blood pressure research $n Kidney Blood Press Res $x MED00003064
GRA    __
$a NT11405 $p MZ0
LZP    __
$a Pubmed-20150306

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...